Join Now

Yearly Archives: 2022

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test

By Natalie Themm | Published February 10, 2022

SALT LAKE CITY, Feb. 3, 2022 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central […]

Posted in BioUtah News | Tagged , | Leave a comment

Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital

By Natalie Themm | Published February 10, 2022

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it will be hosting a booth at the upcoming Life Sciences Day on the Hill on February 16, 2022, at the Utah State Capital Building. It is expected that the conference, […]

Posted in BioUtah News | Tagged , | Leave a comment

Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators

By Natalie Themm | Published February 10, 2022

New Nelson Labs Mark offers transparency and confidence in product testing

Posted in BioUtah News | Tagged | Leave a comment

IONIQ Sciences submits De Novo application to FDA for IONIQ ProLung Test

By admin | Published February 3, 2022

Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has filed a De Novo application with the U.S. Food and Drug Administration (the “FDA”) for its IONIQ ProLung Test™ used for lung cancer. Mr. Jared Bauer, IONIQ Sciences CEO, stated, “Today we submitted our De […]

Posted in BioUtah News | Leave a comment

Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage

By Natalie Themm | Published February 2, 2022

Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity

Posted in BioUtah News | Tagged , | Leave a comment

Biomerics Announces Expansion in Costa Rica With New Plant in Cartago

By Natalie Themm | Published January 27, 2022

Biomerics inaugurated its second plant in Costa Rica.

Posted in BioUtah News | Tagged | Leave a comment

GPX Embolic Device Success in Challenging Tumor Case

By Natalie Themm | Published January 20, 2022

Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors

Posted in BioUtah News | Tagged , | Leave a comment

Foldax Appoints Scott Huennekens to Board of Directors

By Natalie Themm | Published January 19, 2022

Foldax Appoints Scott Huennekens to Board of Directors

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication

By Natalie Themm | Published January 19, 2022

PolarityTE, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers.

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test

By Natalie Themm | Published January 13, 2022

Co-Diagnostics, Inc. announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAGENE™ Human Papillomavirus High-Risk (HPV-HR) Real-Time PCR test as an in vitro diagnostic (“IVD”)

Posted in BioUtah News | Tagged , | Leave a comment

New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

By Natalie Themm | Published January 12, 2022

New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

Posted in BioUtah News | Tagged | Leave a comment

Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy

By Natalie Themm | Published January 11, 2022

Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members